Cargando…
Radiomic biomarkers of tumor immune biology and immunotherapy response
Immunotherapies are leading to improved outcomes for many cancers, including those with devastating prognoses. As therapies like immune checkpoint inhibitors (ICI) become a mainstay in treatment regimens, many concurrent challenges have arisen – for instance, delineating clinical responders from non...
Autores principales: | Wang, Jarey H., Wahid, Kareem A., van Dijk, Lisanne V., Farahani, Keyvan, Thompson, Reid F., Fuller, Clifton David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076712/ https://www.ncbi.nlm.nih.gov/pubmed/33937530 http://dx.doi.org/10.1016/j.ctro.2021.03.006 |
Ejemplares similares
-
Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network
por: Taku, Nicolette, et al.
Publicado: (2022) -
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
por: Trebeschi, S, et al.
Publicado: (2019) -
Meeting the Challenge of Scientific Dissemination in the Era of COVID-19: Toward a Modular Approach to Knowledge-Sharing for Radiation Oncology
por: Fuller, Clifton D., et al.
Publicado: (2020) -
Role of radiomics in predicting immunotherapy response
por: Kothari, Gargi
Publicado: (2022) -
Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System
por: Ji, Zhi, et al.
Publicado: (2020)